Captrust Financial Advisors Royalty Pharma PLC Transaction History

Captrust Financial Advisors

$38.8 Billion
Q1 2025

A detailed history of Captrust Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 12,087 shares of RPRX stock, worth $407,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,087

Previous 14,829 18.49%

Holding current value

$407,936

Previous $378,000 0.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$25.75 - $33.86 $70,606 - $92,844	-2,742 Reduced 18.49%	12,087 $376,000
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $352,035 - $411,626	-14,499 Reduced 49.44%	14,829 $378,000
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $40,905 - $46,714	-1,596 Reduced 5.16%	29,328 $829,000
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $66,569 - $75,796	-2,535 Reduced 7.58%	30,924 $815,000
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $153,473 - $175,103	-5,589 Reduced 14.31%	33,459 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $468,425 - $522,219	-17,872 Reduced 31.4%	39,048 $1.1 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $124,603 - $148,898	-4,745 Reduced 7.69%	56,920 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $769 - $950	26 Added 0.04%	61,665 $1.9 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $131,047 - $157,560	-3,999 Reduced 6.09%	61,639 $2.22 Million
Q4 2022 Feb 15, 2023	BUY	$39.17 - $44.04 $58,128 - $65,355	1,484 Added 2.31%	65,638 $2.59 Million
Q3 2022 Nov 16, 2022	BUY	$39.88 - $44.65 $2.55 Million - $2.85 Million	63,866 Added 22175.69%	64,154 $2.58 Million
Q2 2022 Aug 23, 2022	SELL	$37.53 - $44.22 $19,403 - $22,861	-517 Reduced 64.22%	288 $12,000
Q2 2022 Aug 16, 2022	BUY	$37.53 - $44.22 $20,491 - $24,144	546 Added 210.81%	805 $34,000
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $4,195 - $4,753	112 Added 76.19%	259 $10,000
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $2,110 - $2,548	-60 Reduced 28.99%	147 $6,000
Q3 2021 Nov 16, 2021	BUY	$36.14 - $42.24 $7,228 - $8,448	200 Added 2857.14%	207 $7,000
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $278 - $326	7 New	7 $0

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.8B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Royalty Pharma PLC Transaction History